PRAZIQUANTEL - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for praziquantel and what is the scope of patent protection?
Praziquantel
is the generic ingredient in two branded drugs marketed by Bayer Hlthcare and Endo Operations, and is included in two NDAs. Additional information is available in the individual branded drug profile pages.There are eight drug master file entries for praziquantel. Two suppliers are listed for this compound.
Summary for PRAZIQUANTEL
US Patents: | 0 |
Tradenames: | 2 |
Applicants: | 2 |
NDAs: | 2 |
Drug Master File Entries: | 8 |
Finished Product Suppliers / Packagers: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 146 |
Clinical Trials: | 51 |
Patent Applications: | 5,588 |
Drug Prices: | Drug price trends for PRAZIQUANTEL |
What excipients (inactive ingredients) are in PRAZIQUANTEL? | PRAZIQUANTEL excipients list |
DailyMed Link: | PRAZIQUANTEL at DailyMed |
Recent Clinical Trials for PRAZIQUANTEL
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Kintampo Health Research Centre, Ghana | N/A |
London School of Hygiene and Tropical Medicine | N/A |
Université de Thies, UFR Santé, Senegal | N/A |
Pharmacology for PRAZIQUANTEL
Drug Class | Anthelmintic |
Medical Subject Heading (MeSH) Categories for PRAZIQUANTEL
Anatomical Therapeutic Chemical (ATC) Classes for PRAZIQUANTEL
US Patents and Regulatory Information for PRAZIQUANTEL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Endo Operations | PRAZIQUANTEL | praziquantel | TABLET;ORAL | 208820-001 | Nov 27, 2017 | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Bayer Hlthcare | BILTRICIDE | praziquantel | TABLET;ORAL | 018714-001 | Dec 29, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for PRAZIQUANTEL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Bayer Hlthcare | BILTRICIDE | praziquantel | TABLET;ORAL | 018714-001 | Dec 29, 1982 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.